Advertisement

Loading...

Trulieve Cannabis Corp.

TRUL.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.10
$0.37(4.79%)
Canadian Market opens in 16h 33m

Trulieve Cannabis Corp. Fundamental Analysis

Trulieve Cannabis Corp. (TRUL.CN) shows moderate financial fundamentals with a PE ratio of -9.20, profit margin of -9.87%, and ROE of -9.71%. The company generates $1.0B in annual revenue with moderate year-over-year growth of 5.07%.

Key Strengths

Cash Position16.43%
PEG Ratio-1.43
Current Ratio4.43

Areas of Concern

ROE-9.71%
We analyze TRUL.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 13.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
13.9/100

We analyze TRUL.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

TRUL.CN struggles to generate sufficient returns from assets.

ROA > 10%
-4.26%

Valuation Score

Excellent

TRUL.CN trades at attractive valuation levels.

PE < 25
-9.20
PEG Ratio < 2
-1.43

Growth Score

Excellent

TRUL.CN delivers strong and consistent growth momentum.

Revenue Growth > 5%
5.07%
EPS Growth > 10%
64.04%

Financial Health Score

Excellent

TRUL.CN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.58
Current Ratio > 1
4.43

Profitability Score

Weak

TRUL.CN struggles to sustain strong margins.

ROE > 15%
-971.27%
Net Margin ≥ 15%
-9.87%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TRUL.CN Expensive or Cheap?

P/E Ratio

TRUL.CN trades at -9.20 times earnings. This suggests potential undervaluation.

-9.20

PEG Ratio

When adjusting for growth, TRUL.CN's PEG of -1.43 indicates potential undervaluation.

-1.43

Price to Book

The market values Trulieve Cannabis Corp. at 0.93 times its book value. This may indicate undervaluation.

0.93

EV/EBITDA

Enterprise value stands at 1.68 times EBITDA. This is generally considered low.

1.68

How Well Does TRUL.CN Make Money?

Net Profit Margin

For every $100 in sales, Trulieve Cannabis Corp. keeps $-9.87 as profit after all expenses.

-9.87%

Operating Margin

Core operations generate 12.64 in profit for every $100 in revenue, before interest and taxes.

12.64%

ROE

Management delivers $-9.71 in profit for every $100 of shareholder equity.

-9.71%

ROA

Trulieve Cannabis Corp. generates $-4.26 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.26%

Following the Money - Real Cash Generation

Operating Cash Flow

Trulieve Cannabis Corp. produces operating cash flow of $241.41M, showing steady but balanced cash generation.

$241.41M

Free Cash Flow

Trulieve Cannabis Corp. generates strong free cash flow of $198.95M, providing ample flexibility for dividends, buybacks, or growth.

$198.95M

FCF Per Share

Each share generates $1.18 in free cash annually.

$1.18

FCF Yield

TRUL.CN converts 23.26% of its market value into free cash.

23.26%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-9.20

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.43

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.93

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.80

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.58

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.43

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.10

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How TRUL.CN Stacks Against Its Sector Peers

MetricTRUL.CN ValueSector AveragePerformance
P/E Ratio-9.2027.91 Better (Cheaper)
ROE-9.71%687.00% Weak
Net Margin-9.87%-45285.00% (disorted) Weak
Debt/Equity0.580.33 Weak (High Leverage)
Current Ratio4.432795.76 Strong Liquidity
ROA-4.26%-13557.00% (disorted) Weak

TRUL.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Trulieve Cannabis Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

171.94%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-150.48%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

569.01%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ